QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (111) Citing Articles via Google Scholar Google Scholar Articles by Anson, L. C. Articles by Schoepfer, R. Search for Related Content PubMed PubMed Citation Articles by Anson, L. C. Articles by Schoepfer, R.

Next Article 

The Journal of Neuroscience, January 15, 1998, 18(2):581-589

Identification of Amino Acid Residues of the NR2A Subunit That Control Glutamate Potency in Recombinant NR1/NR2A NMDA Receptors

Lesley C. Anson^{1, 2}, Philip E. Chen^{1, 2}, David J. A. Wyllie², David Colquhoun^{1, 2}, and Ralf Schoepfer^{1, 2}

University College London, ¹ Wellcome Laboratory for Molecular Pharmacology, and ² Department of Pharmacology, London WC1E 6BT, United Kingdom

The NMDA type of ligand-gated glutamate receptor requires the presence of both glutamate and glycine for gating. These receptors are hetero-oligomers of NR1 and NR2 subunits. Previously it was thought that the binding sites for glycine and glutamate were formed by residues on the NR1 subunit. Indeed, it has been shown that the effects of glycine are controlled by residues on the NR1 subunit, and a "Venus flytrap" model for the glycine binding site has been suggested by analogy with bacterial periplasmic amino acid binding proteins. By analysis of 10 mutant NMDA receptors, we now show that residues on the NR2A subunit control glutamate potency in recombinant NR1/NR2A receptors, without affecting glycine potency. Furthermore, we provide evidence that, at least for some mutated residues, the reduced potency of glutamate cannot be explained by alteration of gating but has to be caused primarily by impairing the binding of the agonist to the resting state of the receptor. One NR2A mutant, NR2A(T671A), had an EC₅₀ for glutamate 1000-fold greater than wild type and a 255-fold reduced affinity for APV, yet it had single-channel openings very similar to those of wild type. Therefore we propose that the glutamate binding site is located on NR2 subunits and (taking our data together with previous work) is not on the NR1 subunit. Our data further imply that each NMDA receptor subunit possesses a binding site for an agonist (glutamate or glycine).

Key words: N-methyl-D-aspartate (NMDA); glutamate; receptor; recombinant; subunit; ligand; binding; gating; single-channel; APV; Schild plot; affinity; oocyte; mutant; kinetic

---

Copyright © 1998 Society for Neuroscience  0270-6474/98/182581-09$05.00/0

This article has been cited by other articles:

				H.-R. Chang and C.-C. Kuo The Activation Gate and Gating Mechanism of the NMDA Receptor J. Neurosci., February 13, 2008; 28(7): 1546 - 1556. [Abstract] [Full Text] [PDF]

				G. Tong, H. Takahashi, S. Tu, Y. Shin, M. Talantova, W. Zago, P. Xia, Z. Nie, T. Goetz, D. Zhang, et al. Modulation of NMDA Receptor Properties and Synaptic Transmission by the NR3A Subunit in Mouse Hippocampal and Cerebrocortical Neurons J Neurophysiol, January 1, 2008; 99(1): 122 - 132. [Abstract] [Full Text] [PDF]

				D. C. Wrighton, E. J. Baker, P. E. Chen, and D. J. A. Wyllie Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 211 - 225. [Abstract] [Full Text] [PDF]

				P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 227 - 245. [Abstract] [Full Text] [PDF]

				K. Erreger, M. T. Geballe, A. Kristensen, P. E. Chen, K. B. Hansen, C. J. Lee, H. Yuan, P. Le, P. N. Lyuboslavsky, N. Micale, et al. Subunit-Specific Agonist Activity at NR2A-, NR2B-, NR2C-, and NR2D-Containing N-Methyl-D-aspartate Glutamate Receptors Mol. Pharmacol., October 1, 2007; 72(4): 907 - 920. [Abstract] [Full Text] [PDF]

				P. T. Atlason, M. L. Garside, E. Meddows, P. Whiting, and R. A. J. McIlhinney N-Methyl-D-aspartate (NMDA) Receptor Subunit NR1 Forms the Substrate for Oligomeric Assembly of the NMDA Receptor J. Biol. Chem., August 31, 2007; 282(35): 25299 - 25307. [Abstract] [Full Text] [PDF]

				H.-R. Chang and C.-C. Kuo Characterization of the Gating Conformational Changes in the Felbamate Binding Site in NMDA Channels Biophys. J., July 15, 2007; 93(2): 456 - 466. [Abstract] [Full Text] [PDF]

				M. Awobuluyi, J. Yang, Y. Ye, J. E. Chatterton, A. Godzik, S. A. Lipton, and D. Zhang Subunit-Specific Roles of Glycine-Binding Domains in Activation of NR1/NR3 N-Methyl-D-aspartate Receptors Mol. Pharmacol., January 1, 2007; 71(1): 112 - 122. [Abstract] [Full Text] [PDF]

				P. A. Frizelle, P. E. Chen, and D. J. A. Wyllie Equilibrium Constants for (R)-[(S)-1-(4-Bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic Acid (NVP-AAM077) Acting at Recombinant NR1/NR2A and NR1/NR2B N-Methyl-D-aspartate Receptors: Implications for Studies of Synaptic Transmission Mol. Pharmacol., September 1, 2006; 70(3): 1022 - 1032. [Abstract] [Full Text] [PDF]

				D. J. A. Wyllie, A. R. Johnston, D. Lipscombe, and P. E. Chen Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit J. Physiol., July 15, 2006; 574(2): 477 - 489. [Abstract] [Full Text] [PDF]

				M. Ennis, M. Zhu, T. Heinbockel, and A. Hayar Olfactory Nerve-Evoked, Metabotropic Glutamate Receptor-Mediated Synaptic Responses in Rat Olfactory Bulb Mitral Cells J Neurophysiol, April 1, 2006; 95(4): 2233 - 2241. [Abstract] [Full Text] [PDF]

				K. B. Hansen, R. P. Clausen, E. J. Bjerrum, C. Bechmann, J. R. Greenwood, C. Christensen, J. L. Kristensen, J. Egebjerg, and H. Brauner-Osborne Tweaking Agonist Efficacy at N-Methyl-D-aspartate Receptors by Site-Directed Mutagenesis Mol. Pharmacol., December 1, 2005; 68(6): 1510 - 1523. [Abstract] [Full Text] [PDF]

				S. Schorge, S. Elenes, and D. Colquhoun Maximum likelihood fitting of single channel NMDA activity with a mechanism composed of independent dimers of subunits J. Physiol., December 1, 2005; 569(2): 395 - 418. [Abstract] [Full Text] [PDF]

				M. M. Holm, P. Naur, B. Vestergaard, M. T. Geballe, M. Gajhede, J. S. Kastrup, S. F. Traynelis, and J. Egebjerg A Binding Site Tyrosine Shapes Desensitization Kinetics and Agonist Potency at GluR2: A MUTAGENIC, KINETIC, AND CRYSTALLOGRAPHIC STUDY J. Biol. Chem., October 21, 2005; 280(42): 35469 - 35476. [Abstract] [Full Text] [PDF]

				M. Petrovic, M. Sedlacek, M. Horak, H. Chodounska, and L. Vyklicky Jr 20-Oxo-5{beta}-Pregnan-3{alpha}-yl Sulfate Is a Use-Dependent NMDA Receptor Inhibitor J. Neurosci., September 14, 2005; 25(37): 8439 - 8450. [Abstract] [Full Text] [PDF]

				S. Qiu, Y.-l. Hua, F. Yang, Y.-z. Chen, and J.-h. Luo Subunit Assembly of N-Methyl-D-aspartate Receptors Analyzed by Fluorescence Resonance Energy Transfer J. Biol. Chem., July 1, 2005; 280(26): 24923 - 24930. [Abstract] [Full Text] [PDF]

				L. Kinarsky, B. Feng, D. A. Skifter, R. M. Morley, S. Sherman, D. E. Jane, and D. T. Monaghan Identification of Subunit- and Antagonist-Specific Amino Acid Residues in the N-Methyl-D-aspartate Receptor Glutamate-Binding Pocket J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1066 - 1074. [Abstract] [Full Text] [PDF]

				P. E. Chen, M. T. Geballe, P. J. Stansfeld, A. R. Johnston, H. Yuan, A. L. Jacob, J. P. Snyder, S. F. Traynelis, and D. J. A. Wyllie Structural Features of the Glutamate Binding Site in Recombinant NR1/NR2A N-Methyl-D-aspartate Receptors Determined by Site-Directed Mutagenesis and Molecular Modeling Mol. Pharmacol., May 1, 2005; 67(5): 1470 - 1484. [Abstract] [Full Text] [PDF]

				S. J. Mah, E. Cornell, N. A. Mitchell, and M. W. Fleck Glutamate Receptor Trafficking: Endoplasmic Reticulum Quality Control Involves Ligand Binding and Receptor Function J. Neurosci., March 2, 2005; 25(9): 2215 - 2225. [Abstract] [Full Text] [PDF]

				L. Valluru, J. Xu, Y. Zhu, S. Yan, A. Contractor, and G. T. Swanson Ligand Binding Is a Critical Requirement for Plasma Membrane Expression of Heteromeric Kainate Receptors J. Biol. Chem., February 18, 2005; 280(7): 6085 - 6093. [Abstract] [Full Text] [PDF]

				P. E. Chen, A. R. Johnston, M. H. S. Mok, R. Schoepfer, and D. J. A. Wyllie Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors J. Physiol., July 1, 2004; 558(1): 45 - 58. [Abstract] [Full Text] [PDF]

				M. Papadakis, L. M. Hawkins, and F. A. Stephenson Appropriate NR1-NR1 Disulfide-linked Homodimer Formation Is Requisite for Efficient Expression of Functional, Cell Surface N-Methyl-D-aspartate NR1/NR2 Receptors J. Biol. Chem., April 9, 2004; 279(15): 14703 - 14712. [Abstract] [Full Text] [PDF]

				P. Malherbe, V. Mutel, C. Broger, F. Perin-Dureau, J. A. Kemp, J. Neyton, P. Paoletti, and J. N. C. Kew Identification of Critical Residues in the Amino Terminal Domain of the Human NR2B Subunit Involved in the RO 25-6981 Binding Pocket J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 897 - 905. [Abstract] [Full Text] [PDF]

				S. Schorge and D. Colquhoun Studies of NMDA Receptor Function and Stoichiometry with Truncated and Tandem Subunits J. Neurosci., February 15, 2003; 23(4): 1151 - 1158. [Abstract] [Full Text] [PDF]

				L. Chen, M. Muhlhauser, and C. R. Yang Glycine Tranporter-1 Blockade Potentiates NMDA-Mediated Responses in Rat Prefrontal Cortical Neurons In Vitro and In Vivo J Neurophysiol, February 1, 2003; 89(2): 691 - 703. [Abstract] [Full Text] [PDF]

				H. Ren, Y. Honse, B. J. Karp, R. H. Lipsky, and R. W. Peoples A Site in the Fourth Membrane-associated Domain of the N-Methyl-D-aspartate Receptor Regulates Desensitization and Ion Channel Gating J. Biol. Chem., January 3, 2003; 278(1): 276 - 283. [Abstract] [Full Text] [PDF]

				A. I. Sobolevsky, L. Rooney, and L. P. Wollmuth Staggering of Subunits in NMDAR Channels Biophys. J., December 1, 2002; 83(6): 3304 - 3314. [Abstract] [Full Text] [PDF]

				M. Lampinen, L. Settimo, O. T. Pentikainen, A. Jouppila, D. G. Mottershead, M. S. Johnson, and K. Keinanen Discrimination between Agonists and Antagonists by the alpha -Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid-selective Glutamate Receptor. A MUTATION ANALYSIS OF THE LIGAND-BINDING DOMAIN OF GluR-D SUBUNIT J. Biol. Chem., October 25, 2002; 277(44): 41940 - 41947. [Abstract] [Full Text] [PDF]

				R. Gill, A. Alanine, A. Bourson, B. Buttelmann, G. Fischer, M.-P. Heitz, J. N. C. Kew, B. Levet-Trafit, H.-P. Lorez, P. Malherbe, et al. Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-D-Aspartate Antagonist J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 940 - 948. [Abstract] [Full Text] [PDF]

				T. M. Ballard, M. Pauly-Evers, G. A. Higgins, A.-M. Ouagazzal, V. Mutel, E. Borroni, J. A. Kemp, H. Bluethmann, and J. N. C. Kew Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity J. Neurosci., August 1, 2002; 22(15): 6713 - 6723. [Abstract] [Full Text] [PDF]

				R. Nahum-Levy, E. Tam, S. Shavit, and M. Benveniste Glutamate But Not Glycine Agonist Affinity for NMDA Receptors Is Influenced by Small Cations J. Neurosci., April 1, 2002; 22(7): 2550 - 2560. [Abstract] [Full Text] [PDF]

				K. S. Jones, H. M. A. VanDongen, and A. M. J. VanDongen The NMDA Receptor M3 Segment Is a Conserved Transduction Element Coupling Ligand Binding to Channel Opening J. Neurosci., March 15, 2002; 22(6): 2044 - 2053. [Abstract] [Full Text] [PDF]

				K. Kashiwagi, T. Masuko, C. D. Nguyen, T. Kuno, I. Tanaka, K. Igarashi, and K. Williams Channel Blockers Acting at N-Methyl-D-aspartate Receptors: Differential Effects of Mutations in the Vestibule and Ion Channel Pore Mol. Pharmacol., March 1, 2002; 61(3): 533 - 545. [Abstract] [Full Text] [PDF]

				T. Green, C. A. Rogers, A. Contractor, and S. F. Heinemann NMDA Receptors Formed by NR1 in Xenopus laevis Oocytes Do Not Contain the Endogenous Subunit XenU1 Mol. Pharmacol., February 1, 2002; 61(2): 326 - 333. [Abstract] [Full Text] [PDF]

				Y.-B. Choi, H.-S. V. Chen, and S. A. Lipton Three Pairs of Cysteine Residues Mediate Both Redox and Zn2+ Modulation of the NMDA Receptor J. Neurosci., January 15, 2001; 21(2): 392 - 400. [Abstract] [Full Text] [PDF]

				D. A. Wagner and C. Czajkowski Structure and Dynamics of the GABA Binding Pocket: A Narrowing Cleft that Constricts during Activation J. Neurosci., January 1, 2001; 21(1): 67 - 74. [Abstract] [Full Text] [PDF]

				J. N. C. Kew, A. Koester, J.-L. Moreau, F. Jenck, A.-M. Ouagazzal, V. Mutel, J. G. Richards, G. Trube, G. Fischer, A. Montkowski, et al. Functional Consequences of Reduction in NMDA Receptor Glycine Affinity in Mice Carrying Targeted Point Mutations in the Glycine Binding Site J. Neurosci., June 1, 2000; 20(11): 4037 - 4049. [Abstract] [Full Text] [PDF]

				J. M. Christie, D. E. Jane, and D. T. Monaghan Native N-Methyl-D-aspartate Receptors Containing NR2A and NR2B Subunits Have Pharmacologically Distinct Competitive Antagonist Binding Sites J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1169 - 1174. [Abstract] [Full Text]

				A. I. Sobolevsky, S. G. Koshelev, and B. I. Khodorov Probing of NMDA Channels with Fast Blockers J. Neurosci., December 15, 1999; 19(24): 10611 - 10626. [Abstract] [Full Text] [PDF]

				J. R. Howe REVIEW {blacksquare} : How Glutamate Receptors Are Built Neuroscientist, September 1, 1999; 5(5): 311 - 323. [Abstract] [PDF]

				F. Conti, P. Barbaresi, M. Melone, and A. Ducati Neuronal and Glial Localization of NR1 and NR2A/B Subunits of the NMDA Receptor in the Human Cerebral Cortex Cereb Cortex, March 1, 1999; 9(2): 110 - 120. [Abstract] [Full Text] [PDF]

				R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis The Glutamate Receptor Ion Channels Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62. [Abstract] [Full Text] [PDF]

				W. Danysz and C. G. Parsons Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664. [Abstract] [Full Text] [PDF]

				A. Ivanovic, H. Reilander, B. Laube, and J. Kuhse Expression and Initial Characterization of a Soluble Glycine Binding Domain of the N-Methyl-D-aspartate Receptor NR1 Subunit J. Biol. Chem., August 7, 1998; 273(32): 19933 - 19937. [Abstract] [Full Text] [PDF]

				L.-H. Jiang, F. Rassendren, A. Surprenant, and R. A. North Identification of Amino Acid Residues Contributing to the ATP-binding Site of a Purinergic P2X Receptor J. Biol. Chem., October 27, 2000; 275(44): 34190 - 34196. [Abstract] [Full Text] [PDF]

				E. Meddows, B. Le Bourdelles, S. Grimwood, K. Wafford, S. Sandhu, P. Whiting, and R. A. J. McIlhinney Identification of Molecular Determinants That Are Important in the Assembly of N-Methyl-D-aspartate Receptors J. Biol. Chem., May 25, 2001; 276(22): 18795 - 18803. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help